
The DNA Medicine Institute (AKA: Chan Research, Inc~DNA Medicine Institute) Profile last edited on: 4/1/2023
CAGE: 34SL6
UEI: PUESWMALMKD4
Business Identifier: Med-tech incubator, laboratory, and biomedical technology service provider Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
727 Massachusetts Avenue
Cambridge, MA 02139
Cambridge, MA 02139
(617) 913-7630 |
info@dnamedinstitute.com |
www.dnamedinstitute.com |
Location: Single
Congr. District: 05
County: Middlesex
Congr. District: 05
County: Middlesex
Public Profile
Taking a quite different approach to that of other firms in similar space, DNA Medicine Institute, Inc (DMI) is a medical device company addressing the seamless merging of science and engineering - leveraging an in-depth background in interdisciplinary science to achieve innovative commercial solutions. Describing themselves as a med-tech incubator, laboratory, and biomedical technology service provider, the firm is primarily focused on advancing the rHEALTH diagnostic technology, designed to provide multiple lab values off a single drop of blood. The firm's the rHEALTH technology is being developed for NASAs upcoming mission to Mars effectively to provide comprehensive biomedical analysis for crew members. The firm's developed pPoducts are marketed through partner organizations, either spin-outs from DMI or partner market-facing companies. DNA's e rHEALTH won the XPRIZEs Nokia Sensing XChallenge and was a Finalist in the Qualcomm Tricorder XPRIZE.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
15-19Revenue Range
1.5M-2MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
20-24Awards Distribution by Agency
Most Recent SBIR Projects
Year | Phase | Agency | Total Amount | |
---|---|---|---|---|
1742212387 | 2 | NIH | $1,022,909 | |
Project Title: 5-Minute Point-of-Care Anti-Factor Xa Test for Emergent Patient Management | ||||
2024 | 2 | NIH | $2,473,815 | |
Project Title: FVIII Point-Of-Care Monitoring Device and App | ||||
2018 | 2 | NIH | $4,072,576 | |
Project Title: Stat Palm-Sized Blood Counter | ||||
2015 | 2 | NASA | $1,023,425 | |
Project Title: rHEALTH X with Non-Invasive Capabilities for Science and Crew Health | ||||
2010 | 2 | NASA | $699,998 | |
Project Title: Nanoscale Test Strips for Multiplexed Blood Analysis |
Key People / Management
Eugene Yan-Ho Chan -- Founder, President, and Chief Scientific Officer
Chris Aiston -- Product Engineer and Industrial Design.
Marcus Atkin -- Industrial Designer.
Candice Bae -- Scientist I.
Bill Bauer -- EE/CS
Samuel Bearg -- Special Projects Scientist.
Andy Bell -- Assay Specialist
Dexter Eames -- Electrical Engineer
Chung Han -- Instrumentation Specialist.
Madeline Lee -- Assay Specialist
Lillian Li -- Business Development Associate.
Kevin McKenna -- Software Engineer
William Phipps -- R&D Specialist.
Julia Z Sharpe
Chris Aiston -- Product Engineer and Industrial Design.
Marcus Atkin -- Industrial Designer.
Candice Bae -- Scientist I.
Bill Bauer -- EE/CS
Samuel Bearg -- Special Projects Scientist.
Andy Bell -- Assay Specialist
Dexter Eames -- Electrical Engineer
Chung Han -- Instrumentation Specialist.
Madeline Lee -- Assay Specialist
Lillian Li -- Business Development Associate.
Kevin McKenna -- Software Engineer
William Phipps -- R&D Specialist.
Julia Z Sharpe